Cancer cells must deal with excessive reactive oxygen species (ROS) to survive severe hypoxia and anticancer therapy; however, anti-ROS mechanisms other than the well-known NFE2L2/NRF2 signaling pathway are poorly recognized. Here, we report a ROS scavenging mechanism mediated by HIF1α-KLF4-induced hemoglobin extraeryt...
Bo Zhang, Fei-Chang Liu, Xin-Yue Gao et al.· Signal Transduction and Targ...· 0 citations
This review synthesizes the recent research on hantavirus biology, cellular entry mechanisms, and epidemiological characteristics, and highlights that viral immune evasion and subsequent uncontrolled host immune responses act as the core pathogenic drivers.
Yu-Fang Shi, Mauro Piacentini, A. Zumla et al.· Cell Death & Disease· 0 citations
These findings identify SERPINH1 as a marker of ECM-driven tumour aggressiveness and stromal reprogramming in breast cancer and emerges as a promising prognostic biomarker and a tractable therapeutic target in breast cancer.
M. Scimeca, V. Palumbo, F. Servadei et al.· Biology Direct· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.